Development and commercialization of an innovative rapid HIV-1 incidence assay
Ended Project Grant Awarded Last action
- Award ID
- R44AI114365
- Recipient
-
Sedia Biosciences Corporation UEI LB3AM53JKK33
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,791,483
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Portland, OR 97230, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $791,483 | |
| Original award | $1,000,000 |
Quick answers
Who received award R44AI114365?
R44AI114365 was awarded to Sedia Biosciences Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2014.
How much is award R44AI114365 worth?
$1,791,483 has been obligated on R44AI114365.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award